Evidence map›Paper›PMID 34874418›Full record

Trial reportJAMA2021

Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial.

Yonathan Freund, Anthony Chauvin, Sonia Jimenez, Anne-Laure Philippon, Sonja Curac, Florent Fémy, Judith Gorlicki, Tahar Chouihed, Hélène Goulet, Emmanuel Montassier and 14 more

Registry-linked trialOpen access · bronzeAbstract readEquivalence TrialMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04032769 (MOdified DIagnostic strateGy to Safely ruLe-out Pulmonary Embolism In the Emergency depArtment), which is not on this map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04032769 nacompletednot on this map

MOdified DIagnostic strateGy to Safely ruLe-out Pulmonary Embolism In the Emergency depArtment: A Non-Inferiority Cluster Cross-over Randomized Trial

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2019 to 2020Enrolled1,414ConditionsPulmonary EmbolismArmsMODS (MOdified Diagnostic Strategy)
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Diagnostic Validation of PERC and Resource Utilization in Suspected Acute Pulmonary Embolism: A Systematic Review and Meta-Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  2. Trial
  3. Article
  4. Observational
  5. Observational
  6. Article
  7. Review
  8. Raising the D-dimer bar: a narrative review of the age-adjusted D-dimer threshold.Research and practice in thrombosis and haemostasis · 2026
    Review
  9. Article
  10. Article
  11. Failure rate of the pulmonary embolism rule-out criteria rule for adults 35 years or younger: Findings from the RIETE Registry.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. A software tool for applying Bayes' theorem in medical diagnostics.BMC medical informatics and decision making · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 18 institutions in 3 countries.

Yonathan FreundSorbonne Université, Improving Emergency Care FHU, Paris, France.
Anthony ChauvinEmergency Department, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Sonia JimenezEmergency Department, Hospital Clínic, IDIBAPS, Barcelona, University of Barcelona, Catalonia, Spain.
Anne-Laure PhilipponSorbonne Université, Improving Emergency Care FHU, Paris, France.
Sonja CuracEmergency Department, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France.
Florent FémyEmergency Department, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris University, Paris, France.
Judith GorlickiEmergency Department, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, INSERM U942-MASCOT, Bobigny, France.
Tahar ChouihedEmergency Department, University Hospital of Nancy, Université de Lorraine, UMR_S 1116, Nancy, France.
Hélène GouletEmergency Department, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
Emmanuel MontassierEmergency Department, CHU Nantes, Nantes, France.
Margaux DumontEmergency Department, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Laura Lozano PoloEmergency Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Universitat Autònoma de Barcelona, Catalonia, Spain.
Pierrick Le BorgneEmergency Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Mehdi KhellafEmergency Department, CHU Henri Mondor, INSERM U955, Assistance Publique-Hôpitaux de Paris, Paris, France.
Donia BouzidUniversité de Paris, INSERM, IAME, F-75006 Paris, France.
Pierre-Alexis RaynalEmergency Department, Hôpital St-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
Nizar AbdessaiedEmergency Department, Centre Hospitalier de St Denis, St Denis, France.
Saïd LaribiTours University, Emergency Medicine Department, Tours University Hospital, Tours, France.
Jeremy GuenezanEmergency Department, University Hospital of Poitiers, Poitiers, France.
Olivier GanansiaEmergency Department, Groupe Hospitalier Paris-St Joseph, Paris, France.
Ben BloomEmergency Department, Barts Health NHS Trust, London, United Kingdom.
Oscar MiróEmergency Department, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Marine CachanadoDepartment of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), Assistance Publique-Hôpitaux de Paris, Sorbonne University, St Antoine Hospital, Paris, France.
Tabassome SimonSorbonne Université, Improving Emergency Care FHU, Paris, France.
Assistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Saint-Denis · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire Henri-Mondor · FRHôpital Beaujon · FRHôpital Européen Georges-Pompidou · FRHôpital Paris Saint-Joseph · FRHôpital Tenon · FRHôpitaux Universitaires de Strasbourg · FRHospital de Sant Pau · ESInserm · FRRoyal London Hospital · GBSorbonne Université · FRUniversitat de Barcelona · ESUniversité de Lorraine · FRUniversité de Poitiers · FRUniversité de Tours · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Uncontrolled studies suggest that pulmonary embolism (PE) can be safely ruled out using the YEARS rule, a diagnostic strategy that uses varying D-dimer thresholds. Objective: To prospectively validate the safety of a strategy that combines the YEARS rule with the pulmonary embolism rule-out criteria (PERC) rule and an age-adjusted D-dimer threshold. Design, Settings, and Participants: A cluster-randomized, crossover, noninferiority trial in 18 emergency departments (EDs) in France and Spain. Patients (N = 1414) who had a low clinical risk of PE not excluded by the PERC rule or a subjective clinical intermediate risk of PE were included from October 2019 to June 2020, and followed up until October 2020. Interventions: Each center was randomized for the sequence of intervention periods. In the intervention period (726 patients), PE was excluded without chest imaging in patients with no YEARS criteria and a D-dimer level less than 1000 ng/mL and in patients with 1 or more YEARS criteria and a D-dimer level less than the age-adjusted threshold (500 ng/mL if age <50 years or age in years × 10 in patients ≥50 years). In the control period (688 patients), PE was excluded without chest imaging if the D-dimer level was less than the age-adjusted threshold. Main Outcomes and Measures: The primary end point was venous thromboembolism (VTE) at 3 months. The noninferiority margin was set at 1.35%. There were 8 secondary end points, including chest imaging, ED length of stay, hospital admission, nonindicated anticoagulation treatment, all-cause death, and all-cause readmission at 3 months. Results: Of the 1414 included patients (mean age, 55 years; 58% female), 1217 (86%) were analyzed in the per-protocol analysis. PE was diagnosed in the ED in 100 patients (7.1%). At 3 months, VTE was diagnosed in 1 patient in the intervention group (0.15% [95% CI, 0.0% to 0.86%]) vs 5 patients in the control group (0.80% [95% CI, 0.26% to 1.86%]) (adjusted difference, -0.64% [1-sided 97.5% CI, -∞ to 0.21%], within the noninferiority margin). Of the 6 analyzed secondary end points, only 2 showed a statistically significant difference in the intervention group compared with the control group: chest imaging (30.4% vs 40.0%; adjusted difference, -8.7% [95% CI, -13.8% to -3.5%]) and ED median length of stay (6 hours [IQR, 4 to 8 hours] vs 6 hours [IQR, 5 to 9 hours]; adjusted difference, -1.6 hours [95% CI, -2.3 to -0.9]). Conclusions and Relevance: Among ED patients with suspected PE, the use of the YEARS rule combined with the age-adjusted D-dimer threshold in PERC-positive patients, compared with a conventional diagnostic strategy, did not result in an inferior rate of thromboembolic events. Trial Registration: ClinicalTrials.gov Identifier: NCT04032769.

Indexed as

AdultAgedAged, 80 and overAge FactorsAnticoagulantsCause of DeathConfidence IntervalsCross-Over StudiesEmergency Service, HospitalFemaleFibrin Fibrinogen Degradation ProductsFranceHospitalizationHumansLength of StayMaleAnticoagulantsFibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID34874418
PMCPMC8652602
OpenAlexW4200589799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.